#United States #Echosens #FibroScan #United Digestive #Georgia and Florida

Echosens and United Digestive: A New Era in Liver Diagnostics

In a significant move to enhance patient care in the realm of liver health, Echosens, a pioneer in non-invasive liver diagnostics, has announced its partnership with United Digestive. This collaboration aims to expand the reach of FibroScan® technology to eleven clinics located in Georgia and Florida, marking a notable advancement for early detection of liver diseases.

The FibroScan® device has become an indispensable tool for gastroenterology practices, enabling healthcare providers to assess liver health in a rapid, painless, and cost-effective manner. Patients suffering from obesity, diabetes, metabolic syndromes, or those on long-term medications will particularly benefit from this new service, which enhances risk stratification and helps in the early identification of liver issues.

Dr. John Suh, the Chief Medical Officer at United Digestive, emphasized the impact of obesity and metabolic disorders observed daily in their clinics. He stated, “FibroScan allows us to identify at-risk patients earlier and determine the most appropriate care pathways, whether that's nutrition counseling, lifestyle modifications, referrals to hepatologists, or additional tests and treatments.” This adaptability is crucial, considering that some patients may not respond to current therapies, making the identification of those who qualify for clinical trials evaluating new treatment approaches even more critical.

The importance of early detection in liver disease cannot be overstated. Often, symptoms do not manifest until the condition progresses significantly. FibroScan offers the diagnostic capability to detect advanced liver disease potentially years before any clinical symptoms or complications arise. This is particularly beneficial in cases of fatty liver and mild steatosis, where traditional ultrasound techniques may fall short. Moreover, FibroScan empowers patients, fostering greater awareness of their health and encouraging adherence to treatment plans.

Moreover, Dr. Marc Sonenshine, Executive Vice President of Clinical Initiatives at United Digestive, remarked, “FibroScan is changing how we manage liver health—it's enabling earlier diagnoses and, in turn, earlier interventions. The actionable insights from FibroScan enhance patient education, drive more meaningful engagement, and encourage long-term adherence to care plans.”

The implementation of this technology across the eleven clinics marks a groundbreaking stride in scaling access to vital liver health insights for patients in the Southeast, allowing for timely interventions that could significantly improve overall patient outcomes.

Jon Gingrich, CEO of Echosens North America, noted, “This is what forward-thinking healthcare looks like—getting the right tools in the hands of providers so they can act early and decisively, ultimately improving outcomes for patients.” Gingrich praised United Digestive for its proactive approach in facilitating accessible and actionable liver assessments within the clinic setting.

Looking Ahead: The Future of Liver Health

As both organizations embark on this journey, the anticipation surrounding the partnership is palpable. The goal is to further grow their collaboration, ensuring that even more patients gain access to these critical diagnostics and take proactive steps in managing their liver health. Echosens, with its robust history and global presence, having validated FibroScan through over 5,384 peer-reviewed publications and 218 international guidelines, stands poised to revolutionize liver diagnostics across borders.

About Echosens

As a leader in non-invasive liver assessment, Echosens has transformed the way liver health is monitored through FibroScan®, which is now recognized in over 127 countries. With millions of examinations performed globally, Echosens remains at the forefront of comprehensive liver health management.

About United Digestive

United Digestive, the largest gastroenterology platform in the Southeast, is dedicated to enhancing patient care by leveraging advanced infrastructure and operational insights for GI physicians. The organization is rapidly expanding, and with a strong commitment to quality care, it has grown to include 61 clinics, 22 Ambulatory Surgery Centers (ASCs), and over 220 providers across Georgia, Florida, North Carolina, and South Carolina.

In summary, the partnership between Echosens and United Digestive heralds a new chapter in liver health management, where early detection, patient engagement, and advanced diagnostics converge to foster a healthier society.